E2100: A phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer

Research output: Contribution to journalArticle

109 Scopus citations

Fingerprint Dive into the research topics of 'E2100: A phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer'. Together they form a unique fingerprint.